Yale University

Running trials

• Recruiting

  Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

  NCT07605416· Phase 2· Source

• Recruiting

  Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

  NCT07578116· Phase 3· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

  NCT07723963· Phase 2/3· Source

• Recruiting

  A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

  NCT07214376· Source

• Recruiting

  Rash & Diarrhea Prophylaxis With Capivasertib

  NCT07426822· Phase 2· Source

• Not yet recruiting

  Sac-TMT for Active TNBC Brain Metastases

  NCT07458113· Phase 2· Source

• Recruiting

  Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

  NCT07216391· Phase 2· Source

• Recruiting

  The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

  NCT07610369· Phase 2· Source

• Not yet recruiting

  Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

  NCT06596512· Source

• Recruiting

  Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

  NCT07215910· Phase 3· Source

• Recruiting

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· Phase 3· Source

• Recruiting

  Statins to Prevent Cancer Associated Blood Clots

  NCT07303816· Phase 4· Source

• Active, not recruiting

  Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

  NCT07376655· Source

• Recruiting

  RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

  NCT07136363· Source

• Recruiting

  Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  NCT07621718· Phase 3· Source

• Recruiting

  Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  NCT07142252· Phase 2· Source

• Recruiting

  CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

  NCT07172256· Phase 2· Source

• Recruiting

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  NCT07351045· Phase 3· Source

• Recruiting

  A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  NCT07061574· Phase 1/2· Source

• Recruiting

  Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

  NCT07166406· Phase 3· Source

• Recruiting

  INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

  NCT07224321· Phase 2· Source

• Recruiting

  Investigation of Lymph Node Biology in Kidney Cancer

  NCT07038733· Source

• Active, not recruiting

  Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing

  NCT07281014· Phase 4· Source

• Recruiting

  Iadademstat + SBRT With Atezo in ES-SCLC

  NCT07113691· Phase 1· Source

• Recruiting

  A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

  NCT07226427· Phase 1· Source

• Recruiting

  Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  NCT07271186· Phase 2· Source

• Recruiting

  Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

  NCT07351071· Source

• Recruiting

  Saci Nivo Rela for TNBC

  NCT06963905· Phase 1/2· Source

• Recruiting

  Luspatercept + Darbepoetin in MDS

  NCT07096297· Phase 2· Source

• Recruiting

  Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma

  NCT07048457· Phase 2· Source

• Recruiting

  Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  NCT07061964· Phase 2· Source

• Recruiting

  New Mechanisms of Obesity

  NCT06768827· Source

• Active, not recruiting

  A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07170150· Phase 3· Source

• Recruiting

  Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

  NCT06769126· Phase 2· Source

• Recruiting

  Hyperfractionated Dual Equivalent Fractionated Radiation Therapy

  NCT06898905· Source

• Recruiting

  A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

  NCT06992258· Phase 2· Source

• Recruiting

  Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  NCT07001748· Phase 2/3· Source

• Recruiting

  Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

  NCT07066189· Source

• Recruiting

  Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

  NCT06649812· Phase 2· Source

• Recruiting

  Exploring Water-free Sodium Storage

  NCT06872645· Source

• Recruiting

  A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT07111520· Phase 1/2· Source

• Recruiting

  Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

  NCT06993675· Phase 2· Source

• Recruiting

  Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  NCT06958328· Phase 3· Source

• Recruiting

  Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

  NCT06484062· Phase 1· Source

• Recruiting

  A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

  NCT07070232· Phase 1/2· Source

• Recruiting

  AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

  NCT07027488· Phase 1· Source

• Recruiting

  Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

  NCT06860594· Phase 1· Source

• Recruiting

  A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

  NCT07079631· Phase 1/2· Source

• Recruiting

  Simulation Trial of Telemedical Support for Paramedics

  NCT06441760· Source

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers27 recruiting
• Lung cancer18 recruiting
• Acute myeloid leukemia10 recruiting
• Colorectal cancer9 recruiting
• Heart failure9 recruiting
• Pancreatic cancer9 recruiting
• Ovarian cancer8 recruiting
• Acute lymphoblastic leukaemia7 recruiting
• Myelodysplastic syndromes7 recruiting
• Kidney cancer6 recruiting
• Multiple myeloma6 recruiting
• Sarcoma6 recruiting
• Triple-negative breast cancer6 recruiting
• Chronic kidney disease5 recruiting
• Diffuse large B-cell lymphoma5 recruiting
• Head and neck cancer5 recruiting
• HIV5 recruiting
• Melanoma5 recruiting
• Metastatic breast cancer5 recruiting
• Prostate cancer5 recruiting
• Stroke5 recruiting
• Type 1 diabetes5 recruiting
• Type 2 diabetes4 recruiting
• Bladder cancer3 recruiting
• Chronic myeloid leukaemia3 recruiting
• Coronary artery disease3 recruiting
• Epilepsy3 recruiting
• Gastric and esophageal cancer3 recruiting
• Myeloproliferative neoplasms3 recruiting
• Neuroendocrine tumours3 recruiting
• Parkinson disease3 recruiting
• Alzheimer disease2 recruiting
• Amyloidosis2 recruiting
• Asthma2 recruiting
• Crohn's disease2 recruiting
• Depression2 recruiting
• Endometrial cancer2 recruiting
• Glioblastoma2 recruiting
• High blood pressure2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Mantle cell lymphoma2 recruiting
• Neuroblastoma2 recruiting
• Obesity2 recruiting
• Systemic sclerosis (scleroderma)2 recruiting
• Ulcerative colitis2 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Frontotemporal dementia1 recruiting
• Hodgkin lymphoma1 recruiting
• Liver and biliary tract cancer1 recruiting
• Long COVID and ME/CFS1 recruiting
• Lupus (SLE)1 recruiting
• Multiple sclerosis1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Rheumatoid arthritis1 recruiting
• Sjögren's disease1 recruiting
• Thyroid cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

  NCT06790966· Phase 3· Source

• Completed

  NE3107 in Adults With Neurological Symptoms of Long COVID

  NCT06847191· Phase 2· Source

• Withdrawn

  REVERSE-Long COVID-19 With Baricitinib Study

  NCT05858515· Phase 3· Source

• Completed

  Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

  NCT06377930· Phase 2· Source

• Recruiting

  RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  NCT06121297· Phase 1/2· Source

• Withdrawn

  Neuroimmune Mechanisms in Obesity

  NCT05553405· Phase 1· Source

• Completed

  Tka Assay for CDK4/6i

  NCT06572800· Source

• Recruiting

  A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  NCT06270706· Phase 1· Source

• Terminated

  PArtial REbreathing for Migraine With Aura 1

  NCT05546385· Source

• Completed

  A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers

  NCT05790681· Phase 1· Source

• Completed

  A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID.

  NCT05668091· Phase 2· Source

• Completed

  WHOOP Abnormal Rhythm Notification

  NCT05809362· Source

• Completed

  A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease

  NCT05804383· Phase 1· Source

• Completed

  Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy

  NCT05374564· Phase 1· Source

• Completed

  Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

  NCT05010577· Phase 1/2· Source

• Terminated

  A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

  NCT05269355· Phase 2/3· Source

• Completed

  Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

  NCT05325294· Source

• Completed

  A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

  NCT05388474· Source

• Terminated

  Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma

  NCT04955743· Phase 2· Source

• Completed

  Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI

  NCT05220501· Source

• Terminated

  Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System

  NCT04881162· Source

• Terminated

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy

  NCT04951609· Phase 1· Source

• Completed

  AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

  NCT04895215· Phase 2· Source

• Completed

  Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

  NCT06177691· Source

• Completed

  A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

  NCT04731467· Phase 1/2· Source

• Terminated

  A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

  NCT04844073· Phase 1/2· Source

• Completed

  Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

  NCT04760652· Source

• Completed

  A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia

  NCT04457310· Phase 2· Source

• Completed

  Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients

  NCT05286242· Source

• Completed

  Exploring Outcomes and Characteristics of Myasthenia Gravis 2

  NCT06002945· Source

• Completed

  Stress and Congestive Heart Failure

  NCT04551560· Source

• Completed

  Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

  NCT04495556· Source

• Completed

  First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

  NCT04417465· Phase 1· Source

• Completed

  Human Epilepsy Project 3

  NCT05374928· Source

• Completed

  Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

  NCT04173507· Phase 2· Source

• Completed

  PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

  NCT04129931· Phase 2· Source

• Completed

  Prospective Clinicogenomic Program

  NCT04180176· Phase 4· Source

• Completed

  Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer

  NCT04082364· Phase 2/3· Source

• Completed

  A Trial of Talabostat (BXCL701) and Pembrolizumab in Participants With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype

  NCT03910660· Phase 1/2· Source

• Completed

  TRC-PAD Program: In-Clinic Trial-Ready Cohort

  NCT04004767· Source

• Completed

  Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

  NCT03971474· Phase 2· Source

• Terminated

  Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

  NCT03645928· Phase 2· Source

• Terminated

  A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma

  NCT03866239· Phase 1· Source

• Completed

  Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT03845296· Phase 2· Source

• Terminated

  Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

  NCT03199885· Phase 3· Source

• Completed

  Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

  NCT03768414· Phase 3· Source

• Completed

  Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure

  NCT03440970· Early phase 1· Source

• Completed

  Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

  NCT03789162· Source

• Terminated

  Open-Label Study of AG10 in Patients With Cardiomyopathy

  NCT03536767· Phase 2· Source

• Completed

  Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

  NCT03258554· Phase 2/3· Source